General American Investors’s Gilead Sciences GILD Stock Holding History

General American Investors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18.3M	Buy	144,900 +25,000	+21%	+$3.29M	1.08%	30
2026 Q1	$16.7M	Hold	119,900	–	–	1.1%	32
2025 Q4	$14.7M	Hold	119,900	–	–	0.83%	36
2025 Q3	$13.3M	Hold	119,900	–	–	0.77%	45
2025 Q2	$13.3M	Hold	119,900	–	–	0.85%	38
2025 Q1	$13.4M	Hold	119,900	–	–	0.98%	36
2024 Q4	$11.1M	Sell	119,900 -25,000	-17%	-$2.25M	0.77%	42
2024 Q3	$12.1M	Buy	144,900 +25,000	+21%	+$1.91M	0.84%	43
2024 Q2	$8.23M	Hold	119,900	–	–	0.57%	48
2024 Q1	$8.78M	Hold	119,900	–	–	0.63%	48
2023 Q4	$9.71M	Hold	119,900	–	–	0.77%	42
2023 Q3	$8.99M	Hold	119,900	–	–	0.81%	39
2023 Q2	$9.24M	Hold	119,900	–	–	0.8%	39
2023 Q1	$9.95M	Hold	119,900	–	–	0.94%	37
2022 Q4	$10.3M	Sell	119,900 -21,200	-15%	-$1.68M	1.01%	36
2022 Q3	$8.7M	Hold	141,100	–	–	0.91%	37
2022 Q2	$8.72M	Hold	141,100	–	–	0.88%	39
2022 Q1	$8.39M	Buy	141,100 +40,000	+40%	+$2.56M	0.68%	43
2021 Q4	$7.34M	Buy	101,100 +200	+0.2%	+$13.8K	0.58%	50
2021 Q3	$7.05M	Hold	100,900	–	–	0.6%	50
2021 Q2	$6.95M	Hold	100,900	–	–	0.58%	52
2021 Q1	$6.52M	Buy	100,900 +26,000	+35%	+$1.68M	0.61%	50
2020 Q4	$4.36M	Buy	74,900 +50,000	+201%	+$3.02M	0.43%	54
2020 Q3	$1.57M	Hold	24,900	–	–	0.18%	63
2020 Q2	$1.92M	Sell	24,900 -60,700	-71%	-$4.65M	0.24%	62
2020 Q1	$6.4M	Sell	85,600 -248,000	-74%	-$17.1M	0.87%	35
2019 Q4	$21.7M	Hold	333,600	–	–	1.99%	15
2019 Q3	$21.1M	Hold	333,600	–	–	2.08%	16
2019 Q2	$22.5M	Hold	333,600	–	–	2.13%	13
2019 Q1	$21.7M	Hold	333,600	–	–	2.15%	12
2018 Q4	$20.9M	Sell	333,600 -40,000	-11%	-$2.8M	2.19%	13
2018 Q3	$28.8M	Sell	373,600 -70,000	-16%	-$5.29M	2.48%	11
2018 Q2	$31.4M	Hold	443,600	–	–	2.86%	7
2018 Q1	$33.4M	Hold	443,600	–	–	3.17%	7
2017 Q4	$31.8M	Sell	443,600 -20,000	-4%	-$1.52M	3.08%	8
2017 Q3	$37.6M	Sell	463,600 -20,000	-4%	-$1.53M	3.56%	5
2017 Q2	$34.2M	Hold	483,600	–	–	3.47%	5
2017 Q1	$32.8M	Hold	483,600	–	–	3.21%	5
2016 Q4	$34.6M	Buy	483,600 +45,000	+10%	+$3.34M	3.5%	5
2016 Q3	$34.7M	Hold	438,600	–	–	3.54%	5
2016 Q2	$36.6M	Hold	438,600	–	–	3.81%	4
2016 Q1	$40.3M	Hold	438,600	–	–	4.16%	4
2015 Q4	$44.4M	Hold	438,600	–	–	4.07%	3
2015 Q3	$43.1M	Buy	438,600 +15,000	+4%	+$1.67M	3.88%	5
2015 Q2	$49.6M	Sell	423,600 -20,000	-5%	-$2.19M	4.08%	2
2015 Q1	$43.5M	Buy	443,600 +30,000	+7%	+$3.05M	3.58%	5
2014 Q4	$39M	Buy	413,600 +15,000	+4%	+$1.55M	3.12%	7
2014 Q3	$42.4M	Sell	398,600 -30,000	-7%	-$2.94M	3.38%	4
2014 Q2	$35.5M	Hold	428,600	–	–	2.89%	8
2014 Q1	$30.4M	Hold	428,600	–	–	2.54%	9
2013 Q4	$32.2M	Hold	428,600	–	–	2.61%	11
2013 Q3	$26.9M	Hold	428,600	–	–	2.34%	15
2013 Q2	$22M	Buy	+428,600	New	+$22.3M	2%	18

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

General American Investors's GILD Position: Q2 2026 in Review

General American Investors increased its Gilead Sciences (GILD) stake by 21% in Q2 2026, buying an estimated $3.29M and bringing the position to 144,900 shares worth $18.3M. The position accounts for 1.08% of the portfolio, ranked #30.

General American Investors first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $49.6M in Q2 2015. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

General American Investors held 144,900 shares of Gilead Sciences worth $18.3M as of Q2 2026.
General American Investors bought 25,000 Gilead Sciences shares in Q2 2026, an estimated $3.29M.
Gilead Sciences made up 1.08% of General American Investors's portfolio in Q2 2026, its #30 holding.
General American Investors first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
General American Investors's Gilead Sciences position peaked at $49.6M in Q2 2015.
2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on General American Investors's 13F filing for Q2 2026, filed 31 Jul 2026.